Deutsche Bank
ZSAN

Deutsche Bank’s Zosano Pharma Corporation ZSAN Stock Holding History

Deutsche Bank’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-637
Closed -$36K – 4572
2020
Q3 		$36K Buy
+637
New +$29.7K ﹤0.01% 4009
2019
Q2 		– Sell
-3
Closed – – 5610
2019
Q1 		$0 Buy
+3
New +$368 ﹤0.01% 5529
2018
Q4 		– Sell
-714
Closed -$102K – 5534
2018
Q3 		$102K Sell
714
-43
-6% -$6.3K ﹤0.01% 4492
2018
Q2 		$108K Buy
757
+751
+12,517% +$113K ﹤0.01% 4522
2018
Q1 		$1K Buy
+6
New +$2.01K ﹤0.01% 5353
2017
Q3 		– Sell
-3
Closed -$3K – 5181
2017
Q2 		$3K Buy
3
+2
+200% +$2.06K ﹤0.01% 4807
2017
Q1 		$1K Sell
1
-35
-97% -$42.2K ﹤0.01% 4844
2016
Q4 		$19K Buy
36
+33
+1,100% +$16.3K ﹤0.01% 4609
2016
Q3 		$1K Buy
+3
New +$2.39K ﹤0.01% 4864
2015
Q3 		– Sell
-8
Closed -$41K – 5412
2015
Q2 		$41K Buy
8
+5
+167% +$30.9K ﹤0.01% 4683
2015
Q1 		$19K Buy
+3
New +$22.5K ﹤0.01% 4676

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deutsche Bank's ZSAN Position: Q4 2020 in Review

Deutsche Bank sold out of Zosano Pharma Corporation (ZSAN) in Q4 2020, closing a stake of 637 shares — an estimated $36K sold.

Deutsche Bank first reported a position in ZSAN in Q1 2015 and held it in 11 quarters. The position peaked at $108K in Q2 2018. 34 funds tracked by Wall St. Rank hold ZSAN as of Q4 2020.

  • Deutsche Bank reported no remaining Zosano Pharma Corporation position as of Q4 2020 after selling out during the quarter.
  • Deutsche Bank sold 637 Zosano Pharma Corporation shares in Q4 2020, an estimated $36K.
  • Deutsche Bank first reported a position in Zosano Pharma Corporation in Q1 2015 and held it in 11 quarters.
  • Deutsche Bank's Zosano Pharma Corporation position peaked at $108K in Q2 2018.
  • 34 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q4 2020.

Based on Deutsche Bank's 13F filing for Q4 2020, filed 16 Feb 2021.